Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size, Status and Forecast 2020-2026

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Biologics Contract Development and Manufacturing Organization(CDMO) Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Biologics Contract Development Services
    • 1.4.3 Biologics Contract Manufacturing Services
  • 1.5 Market by Application
    • 1.5.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Application: 2020 VS 2026
    • 1.5.2 Big Pharma
    • 1.5.3 Small Pharma
    • 1.5.4 Generic Pharma
    • 1.5.5 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Biologics Contract Development and Manufacturing Organization(CDMO) Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Biologics Contract Development and Manufacturing Organization(CDMO) Industry
      • 1.6.1.1 Biologics Contract Development and Manufacturing Organization(CDMO) Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Biologics Contract Development and Manufacturing Organization(CDMO) Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Biologics Contract Development and Manufacturing Organization(CDMO) Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Biologics Contract Development and Manufacturing Organization(CDMO) Market Perspective (2015-2026)
  • 2.2 Biologics Contract Development and Manufacturing Organization(CDMO) Growth Trends by Regions
    • 2.2.1 Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Biologics Contract Development and Manufacturing Organization(CDMO) Historic Market Share by Regions (2015-2020)
    • 2.2.3 Biologics Contract Development and Manufacturing Organization(CDMO) Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Biologics Contract Development and Manufacturing Organization(CDMO) Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Biologics Contract Development and Manufacturing Organization(CDMO) Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Biologics Contract Development and Manufacturing Organization(CDMO) Players by Market Size
    • 3.1.1 Global Top Biologics Contract Development and Manufacturing Organization(CDMO) Players by Revenue (2015-2020)
    • 3.1.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Concentration Ratio
    • 3.2.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Biologics Contract Development and Manufacturing Organization(CDMO) Revenue in 2019
  • 3.3 Biologics Contract Development and Manufacturing Organization(CDMO) Key Players Head office and Area Served
  • 3.4 Key Players Biologics Contract Development and Manufacturing Organization(CDMO) Product Solution and Service
  • 3.5 Date of Enter into Biologics Contract Development and Manufacturing Organization(CDMO) Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Historic Market Size by Type (2015-2020)
  • 4.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Forecasted Market Size by Type (2021-2026)

5 Biologics Contract Development and Manufacturing Organization(CDMO) Breakdown Data by Application (2015-2026)

  • 5.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2015-2020)
  • 5.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2015-2020)
  • 6.2 Biologics Contract Development and Manufacturing Organization(CDMO) Key Players in North America (2019-2020)
  • 6.3 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2015-2020)
  • 6.4 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2015-2020)
  • 7.2 Biologics Contract Development and Manufacturing Organization(CDMO) Key Players in Europe (2019-2020)
  • 7.3 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2015-2020)
  • 7.4 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2015-2020)

8 China

  • 8.1 China Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2015-2020)
  • 8.2 Biologics Contract Development and Manufacturing Organization(CDMO) Key Players in China (2019-2020)
  • 8.3 China Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2015-2020)
  • 8.4 China Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2015-2020)
  • 9.2 Biologics Contract Development and Manufacturing Organization(CDMO) Key Players in Japan (2019-2020)
  • 9.3 Japan Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2015-2020)
  • 9.4 Japan Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2015-2020)
  • 10.2 Biologics Contract Development and Manufacturing Organization(CDMO) Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2015-2020)

11 India

  • 11.1 India Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2015-2020)
  • 11.2 Biologics Contract Development and Manufacturing Organization(CDMO) Key Players in India (2019-2020)
  • 11.3 India Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2015-2020)
  • 11.4 India Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2015-2020)
  • 12.2 Biologics Contract Development and Manufacturing Organization(CDMO) Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2015-2020)
  • 12.4 Central & South America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Lonza
    • 13.1.1 Lonza Company Details
    • 13.1.2 Lonza Business Overview and Its Total Revenue
    • 13.1.3 Lonza Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
    • 13.1.4 Lonza Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2015-2020))
    • 13.1.5 Lonza Recent Development
  • 13.2 Hansen
    • 13.2.1 Hansen Company Details
    • 13.2.2 Hansen Business Overview and Its Total Revenue
    • 13.2.3 Hansen Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
    • 13.2.4 Hansen Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2015-2020)
    • 13.2.5 Hansen Recent Development
  • 13.3 Boehringer Ingelheim BioXcellence
    • 13.3.1 Boehringer Ingelheim BioXcellence Company Details
    • 13.3.2 Boehringer Ingelheim BioXcellence Business Overview and Its Total Revenue
    • 13.3.3 Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
    • 13.3.4 Boehringer Ingelheim BioXcellence Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2015-2020)
    • 13.3.5 Boehringer Ingelheim BioXcellence Recent Development
  • 13.4 Thermo Fisher Scientific
    • 13.4.1 Thermo Fisher Scientific Company Details
    • 13.4.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
    • 13.4.3 Thermo Fisher Scientific Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
    • 13.4.4 Thermo Fisher Scientific Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2015-2020)
    • 13.4.5 Thermo Fisher Scientific Recent Development
  • 13.5 Samsung BioLogics
    • 13.5.1 Samsung BioLogics Company Details
    • 13.5.2 Samsung BioLogics Business Overview and Its Total Revenue
    • 13.5.3 Samsung BioLogics Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
    • 13.5.4 Samsung BioLogics Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2015-2020)
    • 13.5.5 Samsung BioLogics Recent Development
  • 13.6 AGC Biologics
    • 13.6.1 AGC Biologics Company Details
    • 13.6.2 AGC Biologics Business Overview and Its Total Revenue
    • 13.6.3 AGC Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
    • 13.6.4 AGC Biologics Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2015-2020)
    • 13.6.5 AGC Biologics Recent Development
  • 13.7 Catalent
    • 13.7.1 Catalent Company Details
    • 13.7.2 Catalent Business Overview and Its Total Revenue
    • 13.7.3 Catalent Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
    • 13.7.4 Catalent Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2015-2020)
    • 13.7.5 Catalent Recent Development
  • 13.8 Wuxi Biologics
    • 13.8.1 Wuxi Biologics Company Details
    • 13.8.2 Wuxi Biologics Business Overview and Its Total Revenue
    • 13.8.3 Wuxi Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
    • 13.8.4 Wuxi Biologics Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2015-2020)
    • 13.8.5 Wuxi Biologics Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Biologics Contract Development and Manufacturing Organization(CDMO) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biologics Contract Development and Manufacturing Organization(CDMO) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Lonza
    Hansen
    Boehringer Ingelheim BioXcellence
    Thermo Fisher Scientific
    Samsung BioLogics
    AGC Biologics
    Catalent
    Wuxi Biologics

    Market segment by Type, the product can be split into
    Biologics Contract Development Services
    Biologics Contract Manufacturing Services
    Market segment by Application, split into
    Big Pharma
    Small Pharma
    Generic Pharma
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Biologics Contract Development and Manufacturing Organization(CDMO) status, future forecast, growth opportunity, key market and key players.
    To present the Biologics Contract Development and Manufacturing Organization(CDMO) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Biologics Contract Development and Manufacturing Organization(CDMO) are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now